Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky , 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States.
J Nat Prod. 2013 Sep 27;76(9):1627-36. doi: 10.1021/np4003096. Epub 2013 Aug 29.
A set of 37 doxycycline neoglycosides were prepared, mediated via a C-9 alkoxyamino-glycyl-based spacer reminiscent of that of tigecycline. Subsequent in vitro antibacterial assays against representative drug-resistant Gram negative and Gram positive strains revealed a sugar-dependent activity profile and one doxycycline neoglycoside, the 2'-amino-α-D-glucoside conjugate, to rival that of the parent pharmacophore. In contrast, the representative tetracycline-susceptible strain E. coli 25922 was found to be relatively responsive to a range of doxycycline neoglycosides. This study also extends the use of aminosugars in the context of neoglycosylation via a simple two-step strategy anticipated to be broadly applicable for neoglycorandomization.
一组 37 种强力霉素糖基化衍生物被制备出来,通过 C-9 烷氧基氨基糖基间隔基介导,类似于替加环素。随后针对代表性的耐药革兰氏阴性和革兰氏阳性菌株进行的体外抗菌试验显示出一种依赖于糖的活性谱,并且有一种强力霉素糖基化衍生物,即 2'-氨基-α-D-葡糖苷缀合物,与母体药效团相当。相比之下,代表的四环素敏感菌株大肠杆菌 25922 被发现对一系列强力霉素糖基化衍生物相对敏感。这项研究还通过一种简单的两步策略扩展了氨基糖在糖基化中的应用,预计这种策略将广泛适用于糖基随机化。